Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biontech Se ADR
(NQ:
BNTX
)
108.23
+6.09 (+5.96%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biontech Se ADR
< Previous
1
2
3
4
5
6
7
8
9
...
56
57
Next >
This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
November 19, 2024
Via
Benzinga
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
November 15, 2024
To gain an edge, this is what you need to know today.
Via
Benzinga
European And US Vaccine Stocks Are Under Pressure - Here's WHy
November 15, 2024
Vaccine stocks react to Robert F. Kennedy Jr.'s HHS nomination. FDA and NIH express concerns over his anti-vaccine views amid market shifts.
Via
Benzinga
Exposures
Product Safety
The Analyst Landscape: 17 Takes On BioNTech
November 14, 2024
Via
Benzinga
What Analysts Are Saying About BioNTech Stock
November 08, 2024
Via
Benzinga
Breaking Down BioNTech: 16 Analysts Share Their Views
November 06, 2024
Via
Benzinga
Forecasting The Future: 15 Analyst Projections For BioNTech
October 07, 2024
Via
Benzinga
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
November 15, 2024
President-elect Donald Trump tapped widely known vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
Via
Investor's Business Daily
Topics
Government
Exposures
Political
BioNTech Stock Got A IBD RS Rating Lift
November 14, 2024
A Relative Strength Rating upgrade for BioNTech ADR shows improving technical performance.
Via
Investor's Business Daily
BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition
November 13, 2024
BioNTech acquires Biotheus for $800 million plus milestone payments, securing global rights to BNT327/PM8002 and expanding its oncology and R&D presence in China.
Via
Benzinga
BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential
November 09, 2024
Goldman Sachs upgrades BioNTech to Buy, highlighting the potential of its cancer drug BNT327 and forecasting strong future revenue amid shifting company focus.
Via
Benzinga
This Bank of America Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
November 08, 2024
Via
Benzinga
Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction'
November 07, 2024
Donald Trump has said he will give Robert F. Kennedy Jr. a senior role in his incoming administration to advance his "Make America Healthy Again" agenda.
Via
Benzinga
Topics
Government
Exposures
Political
BioNTech Se (BNTX) Q3 2024 Earnings Call Transcript
November 04, 2024
BNTX earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
BioNTech Variant-adapted COVID-19 Vaccines Do Well In Q3
November 04, 2024
BioNTech's Q3 revenue surged to €1.244 billion, reflecting early COVID-19 vaccine approvals. Net profit rose to €198.1 million, and full-year guidance adjusted downward.
Via
Benzinga
Exposures
COVID-19
BioNTech Jumps On Surprise Profit, Wide Sales Beat; But Lowers Outlook
November 04, 2024
The company now expects sales to come in at the lower end of its previous guidance.
Via
Investor's Business Daily
As Stock Market Awaits Election, Palantir, S&P 500 Nuke Leaders Report
November 01, 2024
Amid the election, and a Fed rate vote, earnings season roars ahead.
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising?
October 24, 2024
This drugmaker's lead candidate could become a top-selling cancer therapy.
Via
The Motley Fool
FDA Presses Clinical Hold Button For BioNTech's Partner Late-Stage Trial Of Investigational Lung Cancer Treatment
October 21, 2024
BioNTech's Phase 3 NSCLC trial is paused after varying outcomes. Current participants continue treatment, and other trials remain unaffected.
Via
Benzinga
Exposures
Product Safety
Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology
October 17, 2024
Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle technology without permission in the development of its COVID-19 vaccines.
Via
Benzinga
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
GSK Sues Moderna Alleging mRNA Vaccine Patent Infringement
October 15, 2024
GlaxoSmithKline has filed a lawsuit against Moderna, claiming its mRNA vaccines infringe on GSK's patents. GSK seeks royalties for Moderna's alleged unlicensed use of its groundbreaking vaccine...
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
Pfizer Jumps After Activist Investor Starboard Reportedly Takes $1 Billion Stake
October 07, 2024
Shares peaked near 62 in late 2021, but are now worth less than half of that.
Via
Investor's Business Daily
Uber To Rally Over 33%? Here Are 10 Top Analyst Forecasts For Monday
October 07, 2024
Via
Benzinga
Consumer Tech News (Sept 30-Oct 4): Latest Windows 11 Update Causing Trouble, Apple Accused Of Compelling Employees To Sign Illegal Agreements & More
October 06, 2024
Major tech companies lobby against CA bill regulating AI, Apple faces legal complaints, iPhone users retain devices longer. Google warns Apple app removal.
Via
Benzinga
Topics
Artificial Intelligence
Law Enforcement
Exposures
Artificial Intelligence
Legal
Google DeepMind, BioNtech Unveil AI Lab Assistants To Revolutionize Scientific Research
October 02, 2024
This AI aims to facilitate interdisciplinary collaboration and uncover unexpected connections in scientific research.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Exxon Mobil To $120? Here Are 10 Top Analyst Forecasts For Tuesday
September 24, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 23, 2024
Via
Benzinga
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
September 22, 2024
10 large-cap stocks worst performers in last week: SMMT -23.61%, KSPI -21.66%, BMRN -16.74%, RIVN -13.26%, FDX -11.08%, BNTX -9.01%, AJG -7.17%, CHWY -6.97%, NVO -6.93%, MUSA -6.90%
Via
Benzinga
How BioNTech, Up 25% Over Four Days, Is Riding Summit's Coattails To A Recovery
September 17, 2024
BioNTech is developing a drug similar to Summit's and shares have skyrocketed over the past four trading days.
Via
Investor's Business Daily
Here's Why Everyone's Talking About Summit Therapeutics
September 17, 2024
Find out why positive results from a Summit Therapeutics study keep pushing up BioNTech and Instil Bio stock.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
56
57
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.